-
EP3998270
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3998270
| EP3998270 - ALKYNE DERIVATIVE, PREPARATION METHOD FOR SAME, AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.04.2022 Database last updated on 09.09.2024 | |
| Former | The international publication has been made Status updated on 18.01.2021 | Most recent event Tooltip | 02.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Zhejiang Hisun Pharmaceutical Co., Ltd. No.46 Waisha Road Jiaojiang District Taizhou, Zhejiang 318000 / CN | For all designated states Shanghai Aryl Pharmtech Co., Ltd. Building 3 301 Minqiang Road Songjiang, Shanghai 201612 / CN | [2023/15] |
| Former [2022/19] | For all designated states Zhejiang Hisun Pharmaceutical Co., Ltd. No.46 Waisha Road Jiaojiang District Taizhou, Zhejiang 318000 / CN | ||
| For all designated states Hisun Accuray Therapeutics Co., Ltd. Building 3, 301 Minqiang Road, Songjiang Shanghai 201612 / CN | Inventor(s) | 01 /
LV, Hejun Building 3 301 Minqiang Road, Songjiang Shanghai 201612 / CN | 02 /
MA, Yutao Building 3 301 Minqiang Road, Songjiang Shanghai 201612 / CN | 03 /
QIU, Haibo Building 3 301 Minqiang Road, Songjiang Shanghai 201612 / CN | 04 /
ZHAO, Wenwen Building 3 301 Minqiang Road, Songjiang Shanghai 201612 / CN | 05 /
HU, Taishan Building 3 301 Minqiang Road, Songjiang Shanghai 201612 / CN | 06 /
CHEN, Lei NO.46 Waisha Road, Jiaojiang District Taizhou Zhejiang 318000 / CN | [2022/19] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2022/19] | Application number, filing date | 20837650.9 | 06.07.2020 | [2022/20] | WO2020CN100376 | Priority number, date | CN201910608212 | 08.07.2019 Original published format: CN201910608212 | [2022/19] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021004421 | Date: | 14.01.2021 | Language: | ZH | [2021/02] | Type: | A1 Application with search report | No.: | EP3998270 | Date: | 18.05.2022 | Language: | EN | [2022/20] | Search report(s) | International search report - published on: | CN | 14.01.2021 | (Supplementary) European search report - dispatched on: | EP | 15.06.2023 | Classification | IPC: | C07D487/04, A61K31/519, A61K45/06, A61P35/00, A61P19/00, A61P11/00, A61P29/00, A61P37/00, A61P11/06, A61P35/02 | [2022/19] | CPC: |
A61P11/00 (EP,CN);
C07D487/04 (EP,CN);
A61K31/519 (EP,US);
A61K45/06 (EP,CN,US);
A61P11/06 (EP,CN);
A61P19/00 (EP,CN);
A61P29/00 (EP,CN);
A61P35/00 (EP,CN);
A61P35/02 (EP,CN);
A61P37/00 (EP,CN)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/19] | Title | German: | ALKINDERIVAT, VERFAHREN ZU SEINER HERSTELLUNG UND SEINE VERWENDUNGEN | [2022/19] | English: | ALKYNE DERIVATIVE, PREPARATION METHOD FOR SAME, AND USES THEREOF | [2022/19] | French: | DÉRIVÉ ALCYNE, SON PROCÉDÉ DE PRÉPARATION ET SES UTILISATIONS | [2022/19] | Entry into regional phase | 20.01.2022 | Translation filed | 20.01.2022 | National basic fee paid | 20.01.2022 | Search fee paid | 20.01.2022 | Designation fee(s) paid | 20.01.2022 | Examination fee paid | Examination procedure | 20.01.2022 | Examination requested [2022/20] | 22.12.2023 | Amendment by applicant (claims and/or description) | 22.12.2023 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 26.07.2022 | Renewal fee patent year 03 | 23.06.2023 | Renewal fee patent year 04 | 01.07.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2015051244 (INFINITY PHARMACEUTICALS INC [US]) [I] 1-14* example -; claim -; table 2 * |